3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Ovarian Epithelial Cancer Recurrent
1
Locally Advanced Gastric Cancer
1
Interventions
Fluorouracil
7
Oxaliplatin
6
Nivolumab
5
Leucovorin
5
fludarabine
4
Cyclophosphamide
4
Capecitabine
4
zimberelimab
3
pembrolizumab
3
aldesleukin
3
Trastuzumab
3
Paclitaxel
3
Docetaxel
3
ulixertinib
2
trastuzumab deruxtecan
2
fludarabine phosphate
2
Specimen Handling
2
Ramucirumab
2
Irinotecan
2
zolbetuximab
1
zanidatamab
1
trifluridine tipiracil drug combination
1
trastuzumab biosimilar HLX02
1
trametinib
1
tislelizumab
1
sodium propionate
1
sapanisertib
1
relatlimab
1
quemliclustat
1
propionic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Hyperthermic Intraperitoneal Chemotherapy
×
30 days
×
Clear all
NCT07133490
2026-06-01
INTERACT Stomach-II
Erasmus Medical Center
Phase 2
Recruiting
55 enrolled